Actively Recruiting
Functional Assessment of Patients with Chemotherapy-Induced Peripheral Neuropathy Compared to Controls
Led by Paracelsus Medical University · Updated on 2026-08-19
120
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Chemotherapy-induced peripheral neuropathy CIPN is a common and serious side effect of certain cancer treatments, causing symptoms like tingling and numbness in the hands and feet that reduce quality of life and independence. This research evaluates functional impairments in people with CIPN compared to healthy individuals and chemotherapy patients without CIPN. It aims to develop objective tests to measure daily activity limitations alongside patients reported symptoms, helping to better understand and assess CIPN. The study will compare three groups patients with CIPN, chemotherapy patients without CIPN, and healthy matched controls. Participants will complete questionnaires about their symptoms and quality of life, plus a series of functional tests including gait and balance assessments, handgrip strength, a peg test for finger dexterity, and a physical performance battery. These tests will take about 90 minutes and will be used to see how well they correlate with patient-reported symptoms. Participants will be assessed once, with a subgroup of healthy controls repeating the functional tests for reliability. Measurements include questionnaires EORTC QLQ-CIPN20, QLQ-C30, CTCAE grading and functional tests performed under supervision at university medical centers. Researchers will analyze correlations between subjective and objective measures and differences between groups. The study involves minimal risk and will last about one year, with safety and data privacy carefully managed.
CONDITIONS
Brief Title
Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy
Research Team
F
Florian Rieder, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here